New England Biolabs
SomaLogic Scores One-Time, $21.2M Licensing Royalty in Q3, Raises FY 2022 Revenue Guidance
The Boulder, Colorado-based proteomics assay maker beat Wall Street estimates on the top and bottom lines in Q3, driven by higher product revenues.
Element Biosciences Strikes Multiple Partnerships to Integrate Sequencer With Existing NGS Products
The collaborations will make the Aviti platform compatible with NGS products from Roche, Agilent Technologies, New England Biolabs, Qiagen, and Watchmaker Genomics.
EpiCypher, New England Biolabs Partner to Codevelop Epigenomic Library Prep Kits
The companies have created a new, dedicated library preparation kit for EpiCypher's CUT&RUN ChIP-seq technology using NEB's reagents.
Jun 17, 2021
Oct 10, 2019
Oct 11, 2018
Avacta Licenses Affimer Tech to New England Biolabs
Jun 29, 2017